Antibody Analytics
Andrew Baron is the Director of Operations and Head of Research and Development at Antibody Analytics. With a background in various scientific roles at BioOutsource, Roche, and Covance, Andrew specializes in simplifying biosimilar ADCC testing through innovative approaches. Their extensive experience includes managing complex studies, overseeing compliance with regulations, and developing assays for biological drugs. Andrew holds a PhD in Neuroscience, an MRes in Medical and Molecular Biosciences, and a BSc (Hons) in Pharmacology from Newcastle University.
This person is not in any teams
Antibody Analytics
At Antibody Analytics we believe that scientists deserve the best data, and patients deserve the best drugs. Led by a group of talented and engaged scientists, we look at biological problems in an openminded way to deliver beautifully designed, developed and qualified bioassays. We have developed a comprehensive portfolio of assays and platforms that can be tailored to support even the most complex of drug pipelines. Whether designing and developing bespoke bioassays or offering routine analysis on our already established assay platforms, Antibody Analytics has an exceptional track record of delivering beautiful results. http://www.antibodyanalytics.com